SCHEMBL20081012

SCHEMBL20081012

COc1ncccc1-c1cnn2ccc(N3CCN(C=O)CC3)nc12

nearest known ligand 0.69

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ AAK1 Q2M2I8 1/20 0.69
▸ PIM1 P11309 2/20 0.41
▸ PIM2 Q9P1W9 2/20 0.41
▸ HRH4 Q9H3N8 1/20 0.41
▸ SMPD3 Q9NY59 8/20 0.40
▸ FYN P06241 1/20 0.38
▸ NTRK1 P04629 1/20 0.37
▸ GAA P10253 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ JAK2 O60674 1/20 0.36
▸ JAK3 P52333 1/20 0.36
▸ PTK2 Q05397 1/20 0.36
▸ DHFR P00374 1/20 0.36
▸ USP2 O75604 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP3A4 P08684 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30102926 0.85 AAK1 (0.77) AAK1PIM1PIM2HRH4SMPD3
SCHEMBL19466953 0.85 AAK1 (0.77) AAK1PIM1PIM2HRH4SMPD3
SCHEMBL19467027 0.85 AAK1 (0.83) AAK1PIM1PIM2HRH4SMPD3
SCHEMBL20081020 0.85 AAK1 (0.80) AAK1PIM1PIM2HRH4SMPD3
SCHEMBL30102963 0.85 AAK1 (0.76) AAK1PIM1PIM2HRH4SMPD3
SCHEMBL29398488 0.85 AAK1 (0.67) AAK1PIM1PIM2HRH4SMPD3
SCHEMBL17495348 0.85 AAK1 (0.67) AAK1PIM1PIM2HRH4SMPD3
SCHEMBL20081026 0.85 AAK1 (0.50) AAK1PIM1PIM2SMPD3NTRK1
SCHEMBL19466770 0.83 AAK1 (0.79) AAK1HRH4GAANPSR1JAK2
SCHEMBL15261395 0.82 AAK1 (0.77) AAK1GAANPSR1JAK2JAK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2834243-B1 PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE LEXICON PHARMACEUTICALS INC (US) 2018-04-25 — — EP disclosed
Send feedback